IP Verse

Dehmel & Bettenhausen opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Dehmel & Bettenhausen

Patent Number:
EP3323413
Title:
Pharmaceutical Composition Containing Celecoxib And Tramadol
Applicant:
YOO YOUNG PHARM CO., LTD.
Opposition Date:
Jun 2, 2021
Patent Number:
EP3268337
Title:
Methods And Kits For Preparing Radionuclide Complexes
Applicant:
THERAGNOSTICS LIMITED
Opposition Date:
Dec 22, 2020
Patent Number:
EP3144676
Title:
Kit Comprising Antibody Specifically Binding To Complement Factor B Protein And Antibody Specifically Binding To Carbohydrate Antigen 19-9 Protein For Diagnosing Pancreatic Cancer
Applicant:
JW BIOSCIENCE
Opposition Date:
Sep 10, 2020
Patent Number:
EP3331537
Title:
Prophylactic Use Of Inulin Against Sinusitis
Applicant:
SÜDZUCKER AG
Opposition Date:
Jul 9, 2020
Patent Number:
EP2825558
Title:
Combination Therapy For The Treatment Of Ovarian Cancer
Applicant:
F. HOFFMANN-LA ROCHE AG
Opposition Date:
Feb 14, 2020
Patent Number:
EP2618833
Title:
Breast Cancer Therapeutics
Applicant:
IMBA-INSTITUT FÜR MOLEKULARE BIOTECHNOLOGIE GMBH
Opposition Date:
Feb 1, 2019
Patent Number:
EP2969099
Title:
Removal Of Leaked Affinity Purification Ligand
Applicant:
AMGEN INC.
Opposition Date:
Jan 25, 2019
Patent Number:
EP2081550
Title:
Coating Capsules With Active Pharmaceutical Ingredients
Applicant:
RELIANT PHARMACEUTICALS, INC.
Opposition Date:
Jan 17, 2019
Patent Number:
EP2753634
Title:
Method For Preparing Active Form Of Tnfr-Fc Fusion Protein
Applicant:
ARES TRADING S.A.
Opposition Date:
Jul 31, 2018
Patent Number:
EP2704742
Title:
Formulation For Anti- 4 7 Antibody
Applicant:
MILLENNIUM PHARMACEUTICALS, INC.
Opposition Date:
Apr 12, 2018

Latest patents of Dehmel & Bettenhausen opposed by its competitors

Patent:
EP2753634
Grant Date:
Nov 1, 2017
Title:
Method For Preparing Active Form Of Tnfr-Fc Fusion Protein
Oppositions:
1

Competitors of Dehmel & Bettenhausen

AMGEN INC.

ARES TRADING S.A.

DEHMEL & BETTENHAUSEN

Want to track Dehmel & Bettenhausen?

Feel free to send us a message here and we will get back to you